Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000196656 | SCV000251555 | pathogenic | not provided | 2013-08-12 | criteria provided, single submitter | clinical testing | p.Met1? (ATG>?): c.3 G>A in exon 1 of the GFM1 gene (NM_024996.5). The c.3 G>A mutation has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The c.3 G>A mutation alters the initiator Methionine codon, and the resultant protein would be described as p.Met1?" using a question mark to signify that it is not known if the loss of Met1 means that all protein translation is completely prevented or if an abnormal protein is produced using an alternate Met. Therefore, c.3 G>A is expected to be a pathogenic mutation. The variant is found in MITONUC-MITOP panel(s)." |
Natera, |
RCV001273487 | SCV001456569 | pathogenic | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 | 2020-09-16 | no assertion criteria provided | clinical testing |